Medicine and Dentistry
Lupus Nephritis
100%
Biopsy
83%
Glomerulonephritis
82%
Renal Biopsy
79%
Vasculitis
72%
Immunoglobulin A Nephropathy
71%
ANCA Associated Vasculitis
65%
Disease
58%
Proteinuria
50%
Complement Component C4d
46%
Neutrophil Cytoplasmic Antibody
43%
Glomerulopathy
42%
Immunosuppressive Treatment
42%
Pathologist
38%
Nephropathy
37%
Renal Pathology
36%
Systemic Lupus Erythematosus
33%
Kidney Transplantation
32%
Transplantation
32%
Diagnosis
32%
End Stage Renal Disease
31%
Granulomatosis with Polyangiitis
29%
Renal Failure
27%
Rheumatic Disease
27%
Kidney Graft
25%
Nephritic Syndrome
24%
IgA Vasculitis
23%
Autoantibodies
22%
Idiopathic Pulmonary Fibrosis
22%
Focal Segmental Glomerulosclerosis
22%
Kidney Function
21%
Glucocorticoid
21%
Electron Microscopy
21%
Diabetic Nephropathy
20%
Microscopy
20%
Injury
20%
Rituximab
19%
Antiphospholipid Antibody
19%
Glomerular Filtration Rate
18%
Creatinine
18%
Microangiopathy
18%
Recurrent Disease
18%
Calcineurin Inhibitor
17%
Kidney Allograft
17%
Glomerulus
17%
Systematic Review
16%
Pediatrics
16%
Microscopic Polyangiitis
15%
Nephrology
14%
Minimal Change Disease
13%
Keyphrases
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
34%
Lupus Nephritis
32%
IgA Nephropathy (IgAN)
31%
Proteinuria
30%
ANCA-associated Glomerulonephritis
27%
Systemic Lupus Erythematosus
26%
Kidney
23%
Granulomatosis with Polyangiitis
20%
ANCA-associated Vasculitis
20%
Light Microscopy
19%
Glomerular Disease
18%
Glomerular Lesions
18%
Consensus Definition
18%
Electron Microscopy
18%
Kidney Transplantation
18%
Renal Pathology
16%
Risk Score
15%
Dialysis
15%
Clinical Trials
14%
Clinical Outcomes
14%
Kidney Graft Survival
14%
End-stage Kidney Disease
13%
Complete Renal Response
13%
Prediction Tool
13%
ANCA Renal Risk Score
13%
Vasculitis
13%
Clinical Practice
12%
Validation Studies
12%
Classification Criteria
12%
Imlifidase
12%
Histological Classification
12%
EULAR Recommendations
11%
Immunosuppression
11%
Therapeutic Approaches
11%
Antineutrophil Cytoplasmic Antibody
11%
Remission
11%
Rituximab
11%
Renal Outcome
10%
Mixed Classes
10%
Patient Survival
10%
C4d Staining
10%
Confidence Interval
9%
Placebo
9%
Classical Complement Activation
9%
Diabetic Nephropathy
9%
Surrogate Marker
9%
CD163+ Macrophages
9%
Individualized Prediction
9%
Recurrent FSGS
9%
Anti-CD40 Antibody
9%
Immunology and Microbiology
Glomerulonephritis
43%
Kidney Transplantation
38%
Vasculitis
33%
Allotransplantation
31%
Complement Activation
29%
Kidney Function
28%
Complement Component C4d
27%
IgA Nephropathy
27%
Systemic Lupus Erythematosus
27%
Autoantibodies
26%
Transplant Procedure
18%
ANCA Associated Vasculitis
18%
Rheumatic Disease
18%
Acute Graft Rejection
18%
Monospecific Antibody
18%
Immunosuppression
15%
Cyclophosphamide
15%
Neutrophil Cytoplasmic Antibody
12%
Nephritis
12%
Lupus Erythematosus
12%
Imlifidase
12%
Tacrolimus
11%
Chemokine
9%
Macrophage
9%
Immunosuppressive Drug
9%
Fibrogenesis
9%
Mannan-Binding Lectin
9%
Microchimerism
9%
Epidermal Growth Factor
9%
Azathioprine
9%
Methylprednisolone
9%
Transforming Growth Factor Beta
9%
CD163
9%
High Risk Population
9%
Pancreas
9%
Artificial Intelligence
9%
Antiphospholipid Syndrome
9%
Goblet Cell
9%
Human Leukocyte Antigen
9%
Reperfusion
9%
Phospholipid Antibody
9%
Mesenchymal Stem Cell
9%
Squamous Cell
9%
Immunosuppressive Therapy
9%
Anti-Glomerular Basement Membrane Antibody
9%
Immune Complex Deposition
9%
Rituximab
9%
Blood Plasma
7%
Creatinine Blood Level
7%
Placenta
7%
